FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE | 70692-809-74 | Strive Pharmaceuticals Inc. | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 70710-1327-1 | Zydus Pharmaceuticals (USA) Inc. | ANDA210079 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70710-1328-1 | Zydus Pharmaceuticals (USA) Inc. | ANDA210079 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70710-1328-5 | Zydus Pharmaceuticals (USA) Inc. | ANDA210079 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70710-1329-1 | Zydus Pharmaceuticals (USA) Inc. | ANDA210079 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | 70710-1329-5 | Zydus Pharmaceuticals (USA) Inc. | ANDA210079 | HUMAN PRESCRIPTION DRUG | ANDA |
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 70710-1330-1 | Zydus Pharmaceuticals (USA) Inc. | ANDA210079 | HUMAN PRESCRIPTION DRUG | ANDA |
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 70710-1330-5 | Zydus Pharmaceuticals (USA) Inc. | ANDA210079 | HUMAN PRESCRIPTION DRUG | ANDA |
CAFFEINE; BUTALBITAL; ACETAMINOPHEN | 70710-1378-1 | Zydus Pharmaceuticals (USA) Inc. | ANDA211543 | HUMAN PRESCRIPTION DRUG | ANDA |
CAFFEINE; BUTALBITAL; ACETAMINOPHEN | 70710-1378-5 | Zydus Pharmaceuticals (USA) Inc. | ANDA211543 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN | 70729-001-24 | Breeden Brothers, LLC | part343 | HUMAN OTC DRUG | OTC MONOGRAPH NOT FINAL |
ACETAMINOPHEN | 70729-001-50 | Breeden Brothers, LLC | part343 | HUMAN OTC DRUG | OTC MONOGRAPH NOT FINAL |
ACETAMINOPHEN | 70729-175-12 | Breeden Brothers, LLC | part343 | HUMAN OTC DRUG | OTC MONOGRAPH NOT FINAL |
ACETAMINOPHEN; CAFFEINE; BUTALBITAL | 70752-142-10 | QUAGEN PHARMACEUTICALS LLC | ANDA214287 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CAFFEINE; BUTALBITAL | 70752-142-14 | QUAGEN PHARMACEUTICALS LLC | ANDA214287 | HUMAN PRESCRIPTION DRUG | ANDA |
CAFFEINE; BUTALBITAL; ACETAMINOPHEN | 70752-144-10 | QUAGEN PHARMACEUTICALS LLC | ANDA214288 | HUMAN PRESCRIPTION DRUG | ANDA |
CAFFEINE; BUTALBITAL; ACETAMINOPHEN | 70752-144-14 | QUAGEN PHARMACEUTICALS LLC | ANDA214288 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; BUTALBITAL | 70752-147-10 | QUAGEN PHARMACEUTICALS LLC | ANDA214305 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; BUTALBITAL | 70752-147-14 | QUAGEN PHARMACEUTICALS LLC | ANDA214305 | HUMAN PRESCRIPTION DRUG | ANDA |
BUTALBITAL; ACETAMINOPHEN | 70752-148-10 | QUAGEN PHARMACEUTICALS LLC | ANDA214291 | HUMAN PRESCRIPTION DRUG | ANDA |
BUTALBITAL; ACETAMINOPHEN | 70752-148-14 | QUAGEN PHARMACEUTICALS LLC | ANDA214291 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN | 70795-1200-1 | GRAXCELL PHARMACEUTICAL, LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 70795-1200-2 | GRAXCELL PHARMACEUTICAL, LLC | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 70875-500-01 | Simpor Pharma Sdn Bhd | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 70875-500-02 | Simpor Pharma Sdn Bhd | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 70875-500-03 | Simpor Pharma Sdn Bhd | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 70875-500-04 | Simpor Pharma Sdn Bhd | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 70875-500-05 | Simpor Pharma Sdn Bhd | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 70934-555-15 | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | ANDA201013 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 70934-555-30 | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | ANDA201013 | HUMAN PRESCRIPTION DRUG | ANDA |
-